1Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville 22908, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
In situ aromatase activity, not plasma uptake, drives high estradiol levels in postmenopausal breast tumors. Blocking this aromatase may benefit patients, especially those with relapsed estrogen-sensitive breast cancer.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: